DIN 02446057 — REPATHA 140 MG
REPATHA is a solution of Evolocumab marketed by AMGEN CANADA INC. The full Evolocumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02446057
- Brand name
- REPATHA
- Active ingredient
- Evolocumab
- Strength
- 140 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- AMGEN CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Anti-PCSK9 monoclonal antibody (lipid-lowering biologic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.